Kathleen E. Walsh

Insider Reports History

Entity
Individual
Location
C/O Lifemd, Inc., 236 Fifth Avenue, Suite 400, New York, NY
Signature
By: /s/ Christine Bellon, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen E. Walsh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 16.5K $403K $24.40 Jun 6, 2033 Direct
LifeMD, Inc. Director Common Stock 75K $189K $2.52 Dec 15, 2022 Direct
LifeMD, Inc. Director Stock Option (Right to Buy) 37.5K Dec 15, 2022 Direct

Insider Reports Filed by Kathleen E. Walsh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BEAM Beam Therapeutics Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
BEAM Beam Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
LFMD LifeMD, Inc. Dec 15, 2022 2 $0 4 Dec 23, 2022 Director
LFMD LifeMD, Inc. Dec 15, 2022 0 $0 3 Dec 23, 2022 Director
BEAM Beam Therapeutics Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
BEAM Beam Therapeutics Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director